Format
Sort by
Items per page

Send to

Choose Destination

Links from PubChem Compound

Items: 1 to 20 of 5920

1.

First Approved Kinase Inhibitor for AML.

Rasko JEJ, Hughes TP.

Cell. 2017 Nov 16;171(5):981. doi: 10.1016/j.cell.2017.11.007.

PMID:
29149610
2.

Midostaurin in FLT3-Mutated Acute Myeloid Leukemia.

Sahoo RK, Kumar L.

N Engl J Med. 2017 Nov 9;377(19):1901-2. doi: 10.1056/NEJMc1711340. No abstract available.

PMID:
29120133
3.

Midostaurin in FLT3-Mutated Acute Myeloid Leukemia.

Eskazan AE.

N Engl J Med. 2017 Nov 9;377(19):1901. doi: 10.1056/NEJMc1711340. No abstract available.

PMID:
29120132
4.

Midostaurin in FLT3-Mutated Acute Myeloid Leukemia.

Stone RM, Larson RA, Döhner H.

N Engl J Med. 2017 Nov 9;377(19):1903. doi: 10.1056/NEJMc1711340. No abstract available.

5.

Lamin Cleavage: A Reliable Marker for Studying Staurosporine-Induced Apoptosis in Corneal Tissue.

Mahajan S, Thieme D, Czugala M, Kruse FE, Fuchsluger TA.

Invest Ophthalmol Vis Sci. 2017 Nov 1;58(13):5802-5809. doi: 10.1167/iovs.17-21830.

PMID:
29117318
6.

Midostaurin, enasidenib, CPX-351, gemtuzumab ozogamicin, and venetoclax bring new hope to AML.

Wei AH, Tiong IS.

Blood. 2017 Dec 7;130(23):2469-2474. doi: 10.1182/blood-2017-08-784066. Epub 2017 Oct 19. Review.

PMID:
29051180
7.

Midostaurin treatment in FLT3-mutated acute myeloid leukemia and systemic mastocytosis.

Kayser S, Levis MJ, Schlenk RF.

Expert Rev Clin Pharmacol. 2017 Nov;10(11):1177-1189. doi: 10.1080/17512433.2017.1387051. Epub 2017 Oct 10. Review.

PMID:
28960095
8.

Emerging treatments in acute myeloid leukemia: current standards and unmet challenges.

Percival ME, Estey E.

Clin Adv Hematol Oncol. 2017 Aug;15(8):632-642. Review.

PMID:
28949951
9.

Gonadotropin-Dependent Neuregulin-1 Signaling Regulates Female Rat Ovarian Granulosa Cell Survival.

Chowdhury I, Branch A, Mehrabi S, Ford BD, Thompson WE.

Endocrinology. 2017 Oct 1;158(10):3647-3660. doi: 10.1210/en.2017-00065.

PMID:
28938399
10.

Synthesis of piperazine-based thiazolidinones as VEGFR2 tyrosine kinase inhibitors inducing apoptosis.

El-Miligy MM, Abd El Razik HA, Abu-Serie MM.

Future Med Chem. 2017 Oct;9(15):1709-1729. doi: 10.4155/fmc-2017-0072. Epub 2017 Sep 19.

PMID:
28925739
11.

Vaccinia Virus Encodes a Novel Inhibitor of Apoptosis That Associates with the Apoptosome.

Ryerson MR, Richards MM, Kvansakul M, Hawkins CJ, Shisler JL.

J Virol. 2017 Nov 14;91(23). pii: e01385-17. doi: 10.1128/JVI.01385-17. Print 2017 Dec 1.

PMID:
28904196
12.

Triggering of Eryptosis, the Suicidal Erythrocyte Death by Mammalian Target of Rapamycin (mTOR) inhibitor Temsirolimus.

Al Mamun Bhuyan A, Cao H, Lang F.

Cell Physiol Biochem. 2017;42(4):1575-1591. doi: 10.1159/000479398. Epub 2017 Jul 24.

13.

Zinc mediates the neuronal activity-dependent anti-apoptotic effect.

Qiu M, Shentu YP, Zeng J, Wang XC, Yan X, Zhou XW, Jing XP, Wang Q, Man HY, Wang JZ, Liu R.

PLoS One. 2017 Aug 7;12(8):e0182150. doi: 10.1371/journal.pone.0182150. eCollection 2017.

14.

Insulin receptor signaling and glucagon-like peptide 1 effects on pancreatic beta cells.

Caporarello N, Parrino C, Trischitta V, Frittitta L.

PLoS One. 2017 Aug 2;12(8):e0181190. doi: 10.1371/journal.pone.0181190. eCollection 2017.

15.

Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation.

Stone RM, Mandrekar SJ, Sanford BL, Laumann K, Geyer S, Bloomfield CD, Thiede C, Prior TW, Döhner K, Marcucci G, Lo-Coco F, Klisovic RB, Wei A, Sierra J, Sanz MA, Brandwein JM, de Witte T, Niederwieser D, Appelbaum FR, Medeiros BC, Tallman MS, Krauter J, Schlenk RF, Ganser A, Serve H, Ehninger G, Amadori S, Larson RA, Döhner H.

N Engl J Med. 2017 Aug 3;377(5):454-464. doi: 10.1056/NEJMoa1614359. Epub 2017 Jun 23.

PMID:
28644114
16.

Microtubule affinity-regulating kinases are potential druggable targets for Alzheimer's disease.

Annadurai N, Agrawal K, Džubák P, Hajdúch M, Das V.

Cell Mol Life Sci. 2017 Nov;74(22):4159-4169. doi: 10.1007/s00018-017-2574-1. Epub 2017 Jun 20. Review.

PMID:
28634681
17.

Mis-targeting of the mitochondrial protein LIPT2 leads to apoptotic cell death.

Bernardinelli E, Costa R, Scantamburlo G, To J, Morabito R, Nofziger C, Doerrier C, Krumschnabel G, Paulmichl M, Dossena S.

PLoS One. 2017 Jun 19;12(6):e0179591. doi: 10.1371/journal.pone.0179591. eCollection 2017.

18.

Midostaurin: First Global Approval.

Kim ES.

Drugs. 2017 Jul;77(11):1251-1259. doi: 10.1007/s40265-017-0779-0. Review.

PMID:
28612232
19.

Streamlined duplex live-dead microplate assay for cultured cells.

Pfeffer BA, Fliesler SJ.

Exp Eye Res. 2017 Aug;161:17-29. doi: 10.1016/j.exer.2017.05.011. Epub 2017 May 30.

PMID:
28572030
20.

Midostaurin approved for FLT3-mutated AML.

Levis M.

Blood. 2017 Jun 29;129(26):3403-3406. doi: 10.1182/blood-2017-05-782292. Epub 2017 May 25. Review.

PMID:
28546144

Supplemental Content

Support Center